메뉴 건너뛰기




Volumn 8, Issue 6, 2012, Pages 574-578

Generic medications for you, but brand-name medications for me

Author keywords

Attitudes; Beliefs; Generic; Knowledge; Medicine; Perceptions

Indexed keywords

GENERIC DRUG;

EID: 84866077367     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2011.12.004     Document Type: Article
Times cited : (44)

References (17)
  • 1
    • 84870834029 scopus 로고    scopus 로고
    • IMS Health. IMS Health reports U.S. prescription sales grew 5.1 percent in 2009, to $300.3 billion
    • Available at: Accessed 10.10.11.
    • IMS Health. IMS Health reports U.S. prescription sales grew 5.1 percent in 2009, to $300.3 billion. Available at: Accessed 10.10.11. http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=d690a27e9d5b7210VgnVCM100000ed152ca2RCRD.
  • 3
    • 20344361935 scopus 로고    scopus 로고
    • Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000
    • Haas J.S., Phillips K.A., Gerstenberger E.P., Seger A.C. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med 2005, 142:891-897.
    • (2005) Ann Intern Med , vol.142 , pp. 891-897
    • Haas, J.S.1    Phillips, K.A.2    Gerstenberger, E.P.3    Seger, A.C.4
  • 4
    • 79960252970 scopus 로고    scopus 로고
    • The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money
    • Shrank W.H., Choudhry N.K., Liberman J.N., Brennan T.A. The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money. Health Aff (Millwood) 2011, 30:1351-1357.
    • (2011) Health Aff (Millwood) , vol.30 , pp. 1351-1357
    • Shrank, W.H.1    Choudhry, N.K.2    Liberman, J.N.3    Brennan, T.A.4
  • 7
    • 0034186241 scopus 로고    scopus 로고
    • Consumer perceptions of risk and required cost savings for generic prescription drugs
    • Ganther J.M., Kreling D.H. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (Wash) 2000, 40:378-383.
    • (2000) J Am Pharm Assoc (Wash) , vol.40 , pp. 378-383
    • Ganther, J.M.1    Kreling, D.H.2
  • 8
    • 0036674814 scopus 로고    scopus 로고
    • Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution
    • Mott D.A., Cline R.R. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002, 40:662-664.
    • (2002) Med Care , vol.40 , pp. 662-664
    • Mott, D.A.1    Cline, R.R.2
  • 9
    • 34250338174 scopus 로고    scopus 로고
    • What's in a name? Use of brand versus generic drug names in United States outpatient practice
    • Steinman M.A., Chren M.M., Landefeld C.S. What's in a name? Use of brand versus generic drug names in United States outpatient practice. J Gen Intern Med 2007, 22:645-648.
    • (2007) J Gen Intern Med , vol.22 , pp. 645-648
    • Steinman, M.A.1    Chren, M.M.2    Landefeld, C.S.3
  • 10
    • 61849090795 scopus 로고    scopus 로고
    • Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?
    • Shrank W.S., Cadarette S.M., Cox E., et al. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?. Med Care 2009, 47:319-325.
    • (2009) Med Care , vol.47 , pp. 319-325
    • Shrank, W.S.1    Cadarette, S.M.2    Cox, E.3
  • 12
    • 84870812735 scopus 로고    scopus 로고
    • TennCare. Timeline
    • Available at: Accessed 02.12.11.
    • TennCare. Timeline. Available at: Accessed 02.12.11. http://www.tn.gov/tenncare/news-timeline.html.
  • 13
    • 0035704773 scopus 로고    scopus 로고
    • Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS)
    • Nelson D.E., Holtzman D., Bolen J., Stanwyck C.A., Mack K.A. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soz Praventivmed 2001, 46(suppl 1):S3-S42.
    • (2001) Soz Praventivmed , vol.46 , Issue.SUPPL 1
    • Nelson, D.E.1    Holtzman, D.2    Bolen, J.3    Stanwyck, C.A.4    Mack, K.A.5
  • 14
    • 84856477196 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System
    • Available at: Accessed 22.09.11.
    • Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Available at: Accessed 22.09.11. http://www.cdc.gov/brfss/questionnaires/english.htm.
  • 15
    • 53049089162 scopus 로고    scopus 로고
    • Beliefs about generic drugs among elderly adults in hospital-based primary care practices
    • Iosifescu A., Halm E.A., McGinn T., Siu A.L., Federman A.D. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns 2008, 73:377-383.
    • (2008) Patient Educ Couns , vol.73 , pp. 377-383
    • Iosifescu, A.1    Halm, E.A.2    McGinn, T.3    Siu, A.L.4    Federman, A.D.5
  • 16
    • 77249117765 scopus 로고    scopus 로고
    • Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse
    • Piette J.D., Heisler M., Harand A., Juip M. Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse. J Health Care Poor Underserved 2010, 21:349-361.
    • (2010) J Health Care Poor Underserved , vol.21 , pp. 349-361
    • Piette, J.D.1    Heisler, M.2    Harand, A.3    Juip, M.4
  • 17
    • 77958040408 scopus 로고    scopus 로고
    • State generic substitution laws can lower drug outlays under Medicaid
    • Shrank W.H., Choudhry N.K., Agnew-Blais J., et al. State generic substitution laws can lower drug outlays under Medicaid. Health Aff (Millwood) 2010, 29:1383-1390.
    • (2010) Health Aff (Millwood) , vol.29 , pp. 1383-1390
    • Shrank, W.H.1    Choudhry, N.K.2    Agnew-Blais, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.